FindTrial
Sign In

USEFULLNESS OF CORD BLOOD RBC MEAN CORPUSCULAR VOLUME AS A SCREENING TOOL FOR ALPHA THALASSEMIA

UTILITY OF UMBILICAL CORD BLOOD RED BLOOD CELL INDICES MEAN CORPUSCULAR VOLUME IN SCREENING FOR ALPHA THALASSEMIA

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/04/051998
Enrollment
1000
Registered
2023-04-26
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D560- Alpha thalassemia

Interventions

None listed

Sponsors

G Eshwar Goud
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: umbilical cord blood of newborn of more than 36 weeks of period of gestation

Exclusion criteria

Exclusion criteria: patients not consenting for the study

Design outcomes

Primary

MeasureTime frame
To determine the usefulness of cord blood MCV in screening for alpha thalassemiaTimepoint: 1 YEAR—

Secondary

MeasureTime frame
To estimate for prevalence of alpha thalassemia in newborn delivered at Dr. Prabhakar Kore Hospital and To evaluate for other causes of microcytosisTimepoint: after 6months of birth of newborn—

Countries

India

Contacts

Public ContactABHILASHA SAMPAGAR

JAWAHARLAL NEHRU MEDICAL COLLEGE, BELAGAVI.

abhilasha.pedia@gmail.com9686187023

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026